Yahoo Finance Site Map
ArticlesFor a comprehensive guide to our content, please see the Site Index
SiteMap 2023 > 11 > 30
Other dates of the month:
- Bitcoin, gold, and silver should jump as the Fed pivots, but China's yuan faces structural problems, Mike Novogratz says
- Futures edge higher, PCE data ahead, OPEC+ meeting looms - what's moving markets
- Here's Why We Think Greencore Group (LON:GNC) Might Deserve Your Attention Today
- Significant decrease on UGI natural gas bills coming Friday
- Anthony Nunziata returns to The Theater at North with "My Italian Christmas"
- Our Next Energy’s Dual Chemistry Gemini Battery Powers BMW iX 608 Miles on a Single Charge
- Griffin Global Asset Management Aircraft on Lease to Virgin Atlantic Completes Groundbreaking Transatlantic Flight using 100% Sustainable Aviation Fuel
- Factbox-What is Japan's NISA tax-free investment scheme?
- Celebrus Technologies' (LON:CLBS) Dividend Will Be £0.0092
- Some OPEC+ members will cut the oil that they send to the world to try to boost prices
- Japan's Seven & i expands 7-Eleven empire with purchase of Australian franchise
- One Analyst's Revenue Estimates For Journeo plc (LON:JNEO) Are Surging Higher
- Huddled Group Co-Founder Acquires 5.8% More Stock
- Focusrite Full Year 2023 Earnings: EPS Misses Expectations
- UPDATE 7-Henry Kissinger, dominant US diplomat of Cold War era, dies aged 100
- Meta Platforms' ad-free service targeted in EU consumer complaint
- Woolworths Holdings Limited (JSE:WHL) is favoured by institutional owners who hold 56% of the company
- A look at what to expect as latest UN climate talks get under way in oil-rich UAE
- UPDATE 3-Japan's Seven & i expands 7-Eleven empire with purchase of Australian franchise
- Decoding Lowe's Companies Inc (LOW): A Strategic SWOT Insight
- Why The 30% Return On Capital At Renew Holdings (LON:RNWH) Should Have Your Attention
- US stocks close mixed as investors try to solidify big November gains
- 25 Best Cities where You can Retire on $4000 a Month
- Decoding TJX Companies Inc (TJX): A Strategic SWOT Insight
- DSW Capital (LON:DSW) Has Affirmed Its Dividend Of £0.0125
- Bullish Whitehaven Coal Insiders Loaded Up On AU$1.36m Of Stock
- MORNING BID EUROPE-Treasuries on cusp of best month since 2008
- Consolidated Unaudited Interim Report of AS PRFoods for the 1nd quarter and 3 months of 2023/2024 financial year
- Investing in NEXT (LON:NXT) five years ago would have delivered you a 85% gain
- Marketmind: Treasuries on cusp of best month since 2008
- Decoding CrowdStrike Holdings Inc (CRWD): A Strategic SWOT Insight
- Australian copper miner Sandfire says damaged Aboriginal cultural heritage
- JGB yields rebound after two-year bond auction sees poor demand
- Decoding Dollar Tree Inc (DLTR): A Strategic SWOT Insight
- Flash News: American Cancer Society Ventures into Web3 Funding with Gitcoin Grants Stack
- Grammer (ETR:GMM) shareholders have endured a 62% loss from investing in the stock five years ago
- FOREX-Dollar stays near three-month low, focus on inflation data
- GLOBAL MARKETS-Asia stocks close strongest month since January on upbeat outlook
- U.K. Government Warns of Penalties for Unpaid Taxes From Crypto, NFT and Utility Token Holdings
- China factory activity shrinks for 2nd straight month despite stimulus measures
- PRESS DIGEST-New York Times business news - Nov 30
- ASML Supervisory Board intends to appoint Christophe Fouquet as President and Chief Executive Officer
- Eurazeo closes sixth direct-lending fund at €2.3B
- Inside information: Huhtamaki accelerates strategy implementation by starting a three-year program to bring 100 MEUR cost savings
- The scramble to save Saga from sinking under a mountain of debt
- How-to guide: Doing due diligence on VC funds
- Goldilocks meets Santa as global stocks power to best month in three years
- Wereldhave strengthens its credit profile and achieves 2023 financing objectives with new long-term funding from US Private Placement market and Belgian banks
- ObsEva Announces Application for a Moratorium to Facilitate Pivotal Deals
- Samsung Bioepis Secures US License Date for SB17, a Proposed Biosimilar to Stelara®